References
1. Coronavirus COVID-19 global cases by the Center for Systems Science and Engineering. Last accessed 3/29/20 (https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6).
2. Peckham h, de Gruijter N, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, Rosser EC, Deakin C, Webb K. Sex-bias in COVID-19: a meta-analysis and review of sex differences in disease and immunity.
Infectious Disease 2020. 10.21203/rs.3.rs-23651/v1
3. https://www.worldometers.info/coronavirus/coronavirus-symptoms/
4. Breslin N, Baptistec C, Miller R, Fuchs, K, Goffman D, Gyamfi-Bannerman C, D’Alton M. COVID-19 in pregnancy: early lessons. American Journal of Obstetrics and Gynecology 2020
5. Breslin N, Baptiste C, Gyamfi-Bannerman C, Miller R, Martinez R, Bernstein K, Ring L, Landau R, Purisch S, Friedman AM, Fuchs K, Sutton D, Andrikopoulou M, Rupley D, Sheen JJ, Aubey J, Zork N, Moroz L, Mourad M, Wapner R, Simpson LL, D’Alton ME, and Goffman D. COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals. American Journal of Obstetrics & Gynecology MFM. 9 April 2020, 100118
6. Wu C, Yang W, Wu X, Zhang T, Zhao Y, Ren W, Xia J. Clinical manifestation and laboratory characteristics of SARS-CoV-2 infection in pregnant women. Virol Sin . 2020 Apr 20. doi: 10.1007/s12250-020-00227-0
7. Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, Liu Y, Xiao J, Liu H, Deng D, Chen S, Zeng W, Feng L, Wu J. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect Dis. 2020 May;20(5):559-564. doi: 10.1016/S1473-3099(20)30176-6.
8. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020:395;809-815.
9. Sutton D, Fuchs K, D’Alton M, Goffman D. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery. New England Journal of Medicine. DOI: 10.1056/NEJMc2009316
10. Luisi F., Petraglia, Benedetto C, Nappi RE, Bernardi F, Fadalti M, Reis FM, Luisi M, and Genazzani AR. Serum Allopregnanolone Levels in Pregnant Women: Changes during Pregnancy, at Delivery, and in Hypertensive Patients J Clin Endocrinol Metab. 2000 Jul;85(7):2429-33.
11. Kurt D. Pennell, Mark A. Woodin, Page B. Pennell. Quantification of neurosteroids during pregnancy using selective ion monitoring mass spectrometry. Steroids 95 (2015) 24–31
12. Deligiannidis KM, Kroll-Desrosiers AR, Mo S, Nguyen HP, Svenson A, Jaitly N, Hall JE, Barton BA, Rothschild AJ, Shaffer SA. Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression Psychoneuroendocrinology. 2016 Aug; 70: 98–107. doi: 10.1016/j.psyneuen.2016.05.010
13. Meltzer-Brody SE, Kanes SJ. Allopregnanolone in postpartum depression: Role in pathophysiology and treatment. Neurobiology of stress. https://doi.org/10.1016/j.ynstr.2020.1002129.
14. Paul SM, Pinna G, Guidotti A. “Allopregnanolone: From Molecular Pathophysiology to Therapeutics - A Historical Perspective. Neurobiology of Stress. 2020 DOI: 10.1016/j.ynstr.2020.100215
15. Locci A and Pinna G. Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit composition: A biomarker axis in stress-induced cognitive and emotional impairment. British Journal of Pharmacology 174:3226-3241
16. Pinna G, Uzunova V, Matsumoto K, Puia G, Mienville JM, Costa E and Guidotti A: Brain allopregnanolone regulates the potency of the GABAA receptor agonist muscimol. Neuropharmacology 39:440-448. 2000.
17. Maguire JL, Stell BM, Mody I. Ovarian cycle‐linked changes in GABAA receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci 2005; 8: 797– 804.
18. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry. 2000 Jun;157(6):924-30.
19. Wong CG, Bottiglieri T, Snead OC 3rd (2003) GABA, gamma-hydroxybutyric acid, and neurological disease. Ann Neurol 54(Suppl 6):S3–S12.
20. Clarkson AN, Sutherland BA, Appleton I (2005) The biology and pathology of hypoxiaischemia: An update. Arch Immunol Ther Exp (Warsz) 53:213–225.
21. Clarkson AN, et al. (2005) Clomethiazole: Mechanisms underlying lasting neuroprotection following hypoxia-ischemia. FASEB J 19:1036–1038.
22. Reyes-Garcia MG, Hernandez-Hernandez F, Hernandez-Tellez B, Garcia-Tamayo F (2007) GABA (A) receptor subunits RNA expression in mice peritoneal macrophages modulate their IL-6/IL-12 production. J Neuroimmunol 188:64–68.
23. Tian J, et al. (2004) Gamma-aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model. J Immunol 173:5298–5304.
24. Alam S, Laughton DL, Walding A, Wolstenholme AJ (2006) Human peripheral blood mononuclear cells express GABAA receptor subunits. Mol Immunol 43:1432–1442
25. Bergeret M, et al. (1998) GABA modulates cytotoxicity of immunocompetent cells expressing GABAA receptor subunits. Biomed Pharmacother 52:214–219.
26. Bhat R, Axtell R, Mitra A, Miranda M, Lock C, Tsie RW, and Stein L. Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2580-5. doi: 10.1073/pnas.0915139107
27. Suresh K. Mendu, Amol Bhandage, Zhe Jin, Bryndis Birnir. Different Subtypes of GABA-A Receptors Are Expressed in Human, Mouse and Rat T Lymphocytes. https://doi.org/10.1371/journal.pone.0042959
28. Boero G, Porcu P, and A. Leslie Morrow. Pleiotropic actions of allopregnanolone underlie therapeutic benefits in stress-related disease Neurobiol Stress. 2020 May; 12: 100203. Published online 2019 Nov 27. doi: 10.1016/j.ynstr.2019.100203
29. Balan I, Beattie MC, O’Buckley TK, Aurelian L, and Morrow AL. Endogenous Neurosteroid (3α,5α)3-Hydroxypregnan-20-one Inhibits Toll-like-4 Receptor Activation and Pro-inflammatory Signaling in Macrophages and Brain Sci Rep. 2019; 9: 1220. Published online 2019 Feb 4. doi: 10.1038/s41598-018-37409-6
30. Nishel M. Shah, Pei F. Lai, Nesrina Imami, and Mark R. Johnson. Progesterone-Related Immune Modulation of Pregnancy and Labor Front Endocrinol (Lausanne). 2019; 10: 198. Published online 2019 Mar 29. doi: 10.3389/fendo.2019.00198
31. Hall, O., Klein, S. Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites. Mucosal Immunol  10, 1097–1107 (2017). https://doi.org/10.1038/mi.2017.35
32. Vermillion MS, Nelson A, Vom Steeg L, Loube J, Mitzner W, Klein SL. Pregnancy preserves pulmonary function following influenza virus infection in C57BL/6 mice. Am J Physiol Lung Cell Mol Physiol. 2018 Oct 1;315(4):L517-L525. doi: 10.1152/ajplung.00066.2018. Epub 2018 May 31.
33. Goldfarb I , Berk T, Phillippe M. Pregnancy levels of estradiol and progesterone modulate lung inflammation. AJO&G DOI:https://doi.org/10.1016/j.ajog.2014.10.525
34. Maglione A, Rolla S, Mercanti SF, Cutrupi S, Clerico M. The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View. Cells. 2019 Oct 19;8(10). pii: E1280. doi: 10.3390/cells8101280.
35. Ghisletti S, Meda C, Maggi A, and Vegeto E. 17-Estradiol Inhibits Inflammatory Gene Expression by Controlling NF-B Intracellular Localization MOLECULAR AND CELLULAR BIOLOGY, Apr. 2005, p. 2957–2968 Vol. 25, No. 8 0270-7306/05/$08.000 doi:10.1128/MCB.25.8.2957–2968.2005
36. Gubbels Bupp, M.R.; Potluri, T.; Fink, A.L.; Klein, S.L. The Confluence of Sex Hormones and Aging on Immunity. Front. Immunol. 2018, 9, 1269
37. Paris J, Liere P, Kim S, Mahdi F et al., Pregnane steroidogenesis is altered by HIV-1 Tat and morphine: Physiological allopregnanolone is protective against neurotoxic and psychomotor effects https://doi.org/10.1016/j.ynstr.2020.100211
38. Maingat FG, Polyak MJ, Paul AM, Vivithanaporn P, Noorbakhsh F, Ahboucha S, Baker GB, Pearson K, Power C. Neurosteroid-mediated regulation of brain innate immunity in HIV/AIDS: DHEA-S suppresses neurovirulence. Faseb. J., 27 (2013), pp. 725-737, 10.1096/fj.12-215079
39. Butler SA, Cole LA. Evidence for, and Associated Risks with, the Human Chorionic Gonadotropin Supplemented Diet. J Diet Suppl. 2016 Nov;13(6):694-9. doi: 10.3109/19390211.2016.1156208. Epub 2016 Mar 24. Review.
40. Pozzillia P and Lenzib A. Testosterone, a key hormone in the context of COVID-19 pandemic Metabolism. 2020 Apr 27 : 154252. doi: 10.1016/j.metabol.2020.154252 [Epub ahead of print]